Cadus Pharmaceutical Corp., Bristol-Myers Squibb deal

Bristol-Myers made a second equity investment in Cadus of $5 million under their July 1994 joint research agreement. The payment was made for the achievement of an undisclosed scientific milestone in the development of assays that measure signal transduction through G protein-coupled receptors. ...